6-28129780-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025231.3(ZSCAN16):āc.877A>Cā(p.Lys293Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000848 in 1,614,038 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025231.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZSCAN16 | NM_025231.3 | c.877A>C | p.Lys293Gln | missense_variant | 4/4 | ENST00000340487.5 | |
ZSCAN16-AS1 | NR_103456.1 | n.573-6569T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZSCAN16 | ENST00000340487.5 | c.877A>C | p.Lys293Gln | missense_variant | 4/4 | 1 | NM_025231.3 | P1 | |
ZSCAN16-AS1 | ENST00000660873.1 | n.77+6965T>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000310 AC: 78AN: 251264Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135798
GnomAD4 exome AF: 0.000891 AC: 1303AN: 1461836Hom.: 1 Cov.: 31 AF XY: 0.000825 AC XY: 600AN XY: 727214
GnomAD4 genome AF: 0.000427 AC: 65AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.877A>C (p.K293Q) alteration is located in exon 4 (coding exon 3) of the ZSCAN16 gene. This alteration results from a A to C substitution at nucleotide position 877, causing the lysine (K) at amino acid position 293 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at